NEWS

Ankyra Therapeutics Announces Clinical Supply Agreement with Regeneron	11.13.23
Triveni Bio Launches with $92 Million Series A Financing	10.26.23
Ankyra Therapeutics Receives FDA IND Approval to Advance Lead Program, ANK-101, into Human Trials	10.24.23
Ankyra Therapeutics Announces Clinical Trial Collaboration and Supply Agreement with Merck	10.04.23
Orbit Discovery and Orano Med Collaborate to Discover Radioligand Therapies for Cancer	09.11.23
Nature Communications Publication Highlights Evox Therapeutics' Advances	08.09.23

Page 1 of 15